The DOI matches its Crossref record; 233 of the 233 references it cites were found in a registry or an index.
Immune response and immunopathology during toxoplasmosis
Open accessAbstract
Toxoplasma gondii is a protozoan parasite of medical and veterinary significance that is able to infect any warm-blooded vertebrate host. In addition to its importance to public health, several inherent features of the biology of T. gondii have made it an important model organism to study host–pathogen interactions. One factor is the genetic tractability of the parasite, which allows studies on the microbial factors that affect virulence and allows the development of tools that facilitate immune studies. Additionally, mice are natural hosts for T. gondii, and the availability of numerous reagents to study the murine immune system makes this an ideal experimental system to understand the functions of cytokines and effector mechanisms involved in immunity to intracellular microorganisms. In this article, we will review current knowledge of the innate and adaptive immune responses required for resistance to toxoplasmosis, the events that lead to the development of immunopathology, and the natural regulatory mechanisms that limit excessive inflammation during this infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–233 of 233
Mechanisms of innate resistance to Toxoplasma gondii infection
Alexander, J. K., Scharton‐Kersten, T., Yap, G. S., Roberts, C. W., Liew, F. Y., & Sher, A. (1997) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.1997.0120 · Cited by 64
Andrade, R. M., Portillo, J. C., Wessendarp, M., & Subauste, C. S. (2005) · Infection and Immunity · doi:10.1128/iai.73.5.3115-3123.2005 · Cited by 64
Lang, C., Algner, M., Beinert, N., Groß, U., & Lüder, C. G. K. (2006) · Microbes and Infection · doi:10.1016/j.micinf.2006.02.031 · Cited by 63
Benevides, L., Milanezi, C. M., Yamauchi, L. M., Benjamim, C. F., Silva, J. S., & Silva, N. M. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.080129 · Cited by 62
Racine, R., Jones, D. D., Chatterjee, M., McLaughlin, M., MacNamara, K. C., & Winslow, G. M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902710 · Cited by 62
Kinetics and Phenotype of Vaccine-Induced CD8+T-Cell Responses toToxoplasma gondii
Jordan, K. A., Wilson, E. H., Wojno, E. D. T., Fox, B. A., Roos, D. S., Bzik, D. J., Dzierszinski, F. S., & Hunter, C. A. (2009) · Infection and Immunity · doi:10.1128/iai.00024-09 · Cited by 60
Self-citationVillegas, E. N., Lieberman, L. A., Mason, N. J., Blass, S. L., Zediak, V. P., Peach, R., Horan, T., Yoshinaga, S. K., & Hunter, C. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.2.937 · Cited by 60
Self-citationWojno, E. D. T., Jordan, K. A., Dupont, C. D., Harris, T. H., Gregg, B., Wilson, E. H., Pepper, M., Dzierszinski, F. S., Roos, D. S., & Hunter, C. A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903450 · Cited by 59
Self-citationInterleukin-10 downregulates the intracerebral immune response in chronic Toxoplasma encephalitis
Deckert‐Schlüter, M., Buck, C., Weiner, D., Kaefer, N., Rang, A., Hof, H., Wiestler, O. D., & Schlüter, D. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00047-7 · Cited by 59
Israelski, D. M., Araujo, F. G., Conley, F. K., Suzuki, Y., Sharma, S., & Remington, J. S. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.3.954 · Cited by 56
MIF Participates in Toxoplasma gondii-Induced Pathology Following Oral Infection
Cavalcanti, M. G., Mesquita, J. S., Madi, K., Feijó, D. F., Assunção‐Miranda, I., de Souza, H. S. P., & Bozza, M. T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025259 · Cited by 55
Villarino, A. V., Artis, D., Bezbradica, J. S., Miller, O., Saris, C. J. M., Joyce, S., & Hunter, C. A. (2008) · International Immunology · doi:10.1093/intimm/dxn032 · Cited by 55
Self-citationLütjen, S., Soltek, S., Virna, S., Deckert, M., & Schlüter, D. (2006) · Infection and Immunity · doi:10.1128/iai.00098-06 · Cited by 54
Sánchez-Zamora, Y. I., Ruiz‐Rosado, J. D. D., Vega, L., Elizondo, G., Estrada-Muñiz, E., Saavedra, R., Juárez, I., & Rodríguez‐Sosa, M. (2010) · BioMed Research International · doi:10.1155/2010/505694 · Cited by 53
Recognition of Toxoplasma gondii by TLR11 Prevents Parasite-Induced Immunopathology
Yarovinsky, F., Hieny, S. E., & Sher, A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.12.8478 · Cited by 51
Zaretsky, A. G., Silver, J. S., Siwicki, M. R., Durham, A. C., Ware, C. F., & Hunter, C. A. (2012) · Infection and Immunity · doi:10.1128/iai.00333-12 · Cited by 47
Self-citationReichmann, G., Villegas, E. N., Craig, L. E., Peach, R., & Hunter, C. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.6.3354 · Cited by 45
Self-citationEgan, C. E., Craven, M. D., Leng, J., Mack, M., Simpson, K. W., & Denkers, E. (2009) · Mucosal Immunology · doi:10.1038/mi.2009.105 · Cited by 45
Nitric Oxide Mediates the Toxoplasmastatic Activity of Murine Microglial Cellsin vitro
Jun, C., Kim, S. H., Soh, C. T., Kang, S. S., & Chung, H. T. (1993) · Immunological Investigations · doi:10.3109/08820139309084178 · Cited by 43
Egan, C. E., Maurer, K. J., Cohen, S. B., Mack, M., Simpson, K. W., & Denkers, E. (2011) · Mucosal Immunology · doi:10.1038/mi.2011.31 · Cited by 39
Leiva, L. E., Junprasert, J., Hollenbaugh, D. L., & Sorensen, R. U. (1998) · Journal of Clinical Immunology · doi:10.1023/a:1027337923709 · Cited by 37
Pawlowski, N., Khaminets, A., Hunn, J. P., Papic, N., Schmidt, A., Uthaiah, R. C., Lange, R., Vopper, G., Martens, S., Wolf, E., et al. (2011) · BMC Biology · doi:10.1186/1741-7007-9-7 · Cited by 37
Schlüter, D., Meyer, T., Strack, A., Reiter, S., Kretschmar, M., Wiestler, O. D., Hof, H., & Deckert, M. (2001) · Brain Pathology · doi:10.1111/j.1750-3639.2001.tb00380.x · Cited by 36
Li, Z., Manthey, C. L., Perera, P., Sher, A., & Vogel, S. N. (1994) · Infection and Immunity · doi:10.1128/iai.62.8.3434-3440.1994 · Cited by 35
Zhao, Y., Wilson, D. C., Matthews, S., & Yap, G. S. (2007) · Infection and Immunity · doi:10.1128/iai.00738-07 · Cited by 35
Processing and presentation of antigens derived from intracellular protozoan parasites
Goldszmid, R. S., & Sher, A. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.01.017 · Cited by 28
Inhibition of ATF6β-dependent host adaptive immune response by a Toxoplasma virulence factor ROP18
Yamamoto, M., & Takeda, K. (2012) · Virulence · doi:10.4161/viru.3.1.18340 · Cited by 26
Vercammen, M. J., Scorza, T., BOUHDIDI, A. E., et al. (1999) · Parasite Immunology · doi:10.1046/j.1365-3024.1999.00256.x · Cited by 25
Virulence without catalysis: how can a pseudokinase affect host cell signaling?
Reese, M. L., & Boyle, J. P. (2012) · Trends in Parasitology · doi:10.1016/j.pt.2011.12.004 · Cited by 25
CD40 and the immune response to parasitic infections
Subauste, C. S. (2009) · Seminars in Immunology · doi:10.1016/j.smim.2009.06.003 · Cited by 21
Mullarky, I. K., Szaba, F. M., Berggren, K. N., Kummer, L. W., Wilhelm, L. B., Parent, M. A., Johnson, L. L., & Smiley, S. T. (2006) · Infection and Immunity · doi:10.1128/iai.74.2.1181-1188.2006 · Cited by 17
Jordan, K. A., Dupont, C. D., Wojno, E. D. T., Liou, H., & Hunter, C. A. (2010) · International Immunology · doi:10.1093/intimm/dxq439 · Cited by 17
Self-citationAdvances in Imaging The Innate and Adaptive Immune Response to Toxoplasma Gondii
John, B., Weninger, W., & Hunter, C. A. (2010) · Future Microbiology · doi:10.2217/fmb.10.97 · Cited by 16
Self-citation
Research works printed but not linked: 42
- Wolf A, Cowen D, Paige B (1939) Human toxoplasmosis: occurrence in infants as an encephalomyelitis verification by transmission to animals. Science 89(2306):226–227. doi: 10.1126/science.89.2306.226 · doi:10.1126/science.89.2306.226
- Desmonts G, Couvreur J, Alison F, Baudelot J, Gerbeaux J, Lelong M (1965) Epidemiological study on toxoplasmosis: the influence of cooking slaughter-animal meat on the incidence of human infection. Rev Fr Etud Clin Biol 10(9):952–958
- Kean BH, Kimball AC, Christenson WN (1969) An epidemic of acute toxoplasmosis. Jama 208(6):1002–1004 · doi:10.1001/jama.1969.03160060072008
- Frenkel JK (1973) Toxoplasma in and around us. BioScience 23(6):343–352 · doi:10.2307/1296513
- Israelski DM, Remington JS (1988) Toxoplasmic encephalitis in patients with AIDS. Infect Dis Clin North Am 2(2):429–445 · doi:10.1016/s0891-5520(20)30196-3
- Tsuge I, Matsuoka H, Nakagawa A, Kamachi Y, Aso K, Negoro T, Ito M, Torii S, Watanabe K (1998) Necrotizing toxoplasmic encephalitis in a child with the X-linked hyper-IgM syndrome. Eur J Pediatr 157(9):735–737 · doi:10.1007/s004310050925
- Yong PF, Post FA, Gilmour KC, Grosse-Kreul D, King A, Easterbrook P, Ibrahim MA (2008) Cerebral toxoplasmosis in a middle-aged man as first presentation of primary immunodeficiency due to a hypomorphic mutation in the CD40 ligand gene. J Clin Pathol 61(11):1220–1222. doi: 10.1136/jcp.2008.058362 · doi:10.1136/jcp.2008.058362
- Israelski DM, Remington JS (1993) Toxoplasmosis in patients with cancer. Clin Infect Dis 17(Suppl 2):S423–S435 · doi:10.1093/clinids/17.supplement_2.s423
- Dzierszinski FS, Hunter CA (2008) Advances in the use of genetically engineered parasites to study immunity to Toxoplasma gondii. Parasite Immunol 30(4):235–244. doi: 10.1111/j.1365-3024.2007.01016.x · doi:10.1111/j.1365-3024.2007.01016.x
- Cesbron-Delauw MF, Gendrin C, Travier L, Ruffiot P, Mercier C (2008) Apicomplexa in mammalian cells: trafficking to the parasitophorous vacuole. Traffic 9(5):657–664. doi: 10.1111/j.1600-0854.2008.00728.x · doi:10.1111/j.1600-0854.2008.00728.x
- Weilhammer DR, Rasley A (2011) Genetic approaches for understanding virulence in Toxoplasma gondii. Brief Funct Genomics 10(6):365–373. doi: 10.1093/bfgp/elr028 · DOI
- Jenkins MC, Tuo W, Feng X, Cao L, Murphy C, Fetterer R (2010) Neospora caninum: cloning and expression of a gene coding for cytokine-inducing profilin. Exp Parasitol 125(4):357–362. doi: 10.1016/j.exppara.2010.03.001 · doi:10.1016/j.exppara.2010.03.001
- Nakao M, Konishi E (1991) Proliferation of Toxoplasma gondii in human neutrophils in vitro. Parasitology 103(Pt 1):23–27 · doi:10.1017/s0031182000059242
- Konishi E, Nakao M (1992) Naturally occurring immunoglobulin M antibodies: enhancement of phagocytic and microbicidal activities of human neutrophils against Toxoplasma gondii. Parasitology 104(Pt 3):427–432 · doi:10.1017/s003118200006368x
- Aldebert D, Durand F, Mercier C, Brenier-Pinchart MP, Cesbron-Delauw MF, Pelloux H (2007) Toxoplasma gondii triggers secretion of interleukin-12 but low level of interleukin-10 from the THP-1 human monocytic cell line. Cytokine 37(3):206–211. doi: 10.1016/j.cyto.2007.03.012 · doi:10.1016/j.cyto.2007.03.012
- Hammouda NA, Rashwan EA, Hussien ED, Abo el-Naga I, Fathy FM (1995) Measurement of respiratory burst of TNF and IL-1 cytokine activated murine peritoneal macrophages challenged with Toxoplasma gondii. J Egypt Soc Parasitol 25(3):683–691
- Halonen SK, Chiu F, Weiss LM (1998) Effect of cytokines on growth of Toxoplasma gondii in murine astrocytes. Infect Immun 66(10):4989–4993 · doi:10.1128/iai.66.10.4989-4993.1998
- Johnson LL, VanderVegt FP, Havell EA (1993) Gamma interferon-dependent temporary resistance to acute Toxoplasma gondii infection independent of CD4+ or CD8+ lymphocytes. Infect Immun 61(12):5174–5180 · doi:10.1128/iai.61.12.5174-5180.1993
- Hauser WE Jr, Sharma SD, Remington JS (1982) Natural killer cells induced by acute and chronic toxoplasma infection. Cell Immunol 69(2):330–346 · doi:10.1016/0008-8749(82)90076-4
- Subauste CS, Dawson L, Remington JS (1992) Human lymphokine-activated killer cells are cytotoxic against cells infected with Toxoplasma gondii. J Exp Med 176(6):1511–1519 · doi:10.1084/jem.176.6.1511
- Wilson EH, Hunter CA (2008) Immunodominance and recognition of intracellular pathogens. J Infect Dis 198(11):1579–1581. doi: 10.1086/593020 · doi:10.1086/593020
- Subauste CS, Wessendarp M (2006) CD40 restrains in vivo growth of Toxoplasma gondii independently of gamma interferon. Infect Immun 74(3):1573–1579. doi: 10.1128/IAI.74.3.1573-1579.2006 · doi:10.1128/iai.74.3.1573-1579.2006
- Sabin AB, Feldman HA (1948) Dyes as microchemical indicators of a new immunity phenomenon affecting a protozoon parasite (Toxoplasma). Science 108(2815):660–663. doi: 10.1126/science.108.2815.660 · doi:10.1126/science.108.2815.660
- Correa D, Canedo-Solares I, Ortiz-Alegria LB, Caballero-Ortega H, Rico-Torres CP (2007) Congenital and acquired toxoplasmosis: diversity and role of antibodies in different compartments of the host. Parasite Immunol 29(12):651–660. doi: 10.1111/j.1365-3024.2007.00982.x · doi:10.1111/j.1365-3024.2007.00982.x
- Remington JS, Miller MJ, Brownlee I (1968) IgM antibodies in acute toxoplasmosis. II. Prevalence and significance in acquired cases. J Lab Clin Med 71(5):855–866
- Remington JS (1969) The present status of the IgM fluorescent antibody technique in the diagnosis of congenital toxoplasmosis. J Pediatr 75(6):1116–1124 · doi:10.1016/s0022-3476(69)80366-5
- Remington JS, Thulliez P, Montoya JG (2004) Recent developments for diagnosis of toxoplasmosis. J Clin Microbiol 42(3):941–945 · doi:10.1128/jcm.42.3.941-945.2004
- Erbe DV, Pfefferkorn ER, Fanger MW (1991) Functions of the various IgG Fc receptors in mediating killing of Toxoplasma gondii. J Immunol 146(9):3145–3151 · doi:10.4049/jimmunol.146.9.3145
- Hammouda NA, Abo el-Naga I, Hussein ED, Rashwan EA (1995) Opsonization and intracellular killing of Toxoplasma gondii by human mononuclear phagocytes. J Egypt Soc Parasitol 25(1):11–17
- Suzuki M, Tsunematsu Y (1971) Studies on the accessory factor for the toxoplasma dye test: essential role of complement. J Parasitol 57(4):924–925 · doi:10.2307/3277833
- Schreiber RD, Feldman HA (1980) Identification of the activator system for antibody to Toxoplasma as the classical complement pathway. J Infect Dis 141(3):366–369 · doi:10.1093/infdis/141.3.366
- Johnson LL, Gibson GW, Sayles PC (1996) CR3-dependent resistance to acute Toxoplasma gondii infection in mice. Infect Immun 64(6):1998–2003 · doi:10.1128/iai.64.6.1998-2003.1996
- Khan IA, Smith KA, Kasper LH (1988) Induction of antigen-specific parasiticidal cytotoxic T cell splenocytes by a major membrane protein (P30) of Toxoplasma gondii. J Immunol 141(10):3600–3605 · doi:10.4049/jimmunol.141.10.3600
- Gregg B, Dzierszinski F, Tait E, Jordan KA, Hunter CA, Roos DS (2011) Subcellular antigen location influences T-cell activation during acute infection with Toxoplasma gondii. PLoS One 6(7):e22936. doi: 10.1371/journal.pone.0022936 · doi:10.1371/journal.pone.0022936
- Koide M, Kawahara Y, Tsuda T, Yokoyama M (1993) Cytokine-induced expression of an inducible type of nitric oxide synthase gene in cultured vascular smooth muscle cells. FEBS Lett 318(3):213–217 · doi:10.1016/0014-5793(93)80514-u
- Hayashi S, Chan CC, Gazzinelli R, Roberge FG (1996) Contribution of nitric oxide to the host parasite equilibrium in toxoplasmosis. J Immunol 156(4):1476–1481 · doi:10.4049/jimmunol.156.4.1476
- Sibley LD, Messina M, Niesman IR (1994) Stable DNA transformation in the obligate intracellular parasite Toxoplasma gondii by complementation of tryptophan auxotrophy. Proc Natl Acad Sci U S A 91(12):5508–5512 · doi:10.1073/pnas.91.12.5508
- Ronet C, Darche S, Leite de Moraes M, Miyake S, Yamamura T, Louis JA, Kasper LH, Buzoni-Gatel D (2005) NKT cells are critical for the initiation of an inflammatory bowel response against Toxoplasma gondii. J Immunol 175(2):899–908 · doi:10.4049/jimmunol.175.2.899
- Li W, Buzoni-Gatel D, Debbabi H, Hu MS, Mennechet FJD, Durell BG, Noelle RJ, Kasper LH (2002) CD40/CD154 ligation is required for the development of acute ileitis following oral infection with an intracellular pathogen in mice. Gastroenterology 122(3):762–773. doi: 10.1053/Gast.2002.31888 · doi:10.1053/gast.2002.31888
- Nickdel MB, Lyons RE, Roberts F, Brombacher F, Hunter CA, Alexander J, Roberts CW (2004) Intestinal pathology during acute toxoplasmosis is IL-4 dependent and unrelated to parasite burden. Parasite Immunol 26(2):75–82 · doi:10.1111/j.0141-9838.2004.00686.x
- Nickdel MB, Roberts F, Brombacher F, Alexander J, Roberts CW (2001) Counter-protective role for interleukin-5 during acute Toxoplasma gondii infection. Infect Immun 69(2):1044–1052. doi: 10.1128/IAI.69.2.1044-1052.2001 · doi:10.1128/iai.69.2.1044-1052.2001
- Pelloux H, Pernod G, Ricard J, Renversez TC, Ambroise-Thomas P (1994) Interleukin-6 is secreted by human monocytes after stimulation with anti-Toxoplasma gondii sera. J Infect Dis 169(5):1181–1182 · doi:10.1093/infdis/169.5.1181
Cited by
Homeostatic control of regulatory T cell diversity
Liston, A., & Gray, D. H. D. (2014) · Nature Reviews Immunology · doi:10.1038/nri3605 · Cited by 427
Toxoplasma Effectors Targeting Host Signaling and Transcription
Hakimi, M.-A., Olias, P., & Sibley, L. D. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00005-17 · Cited by 339
Toxoplasma gondii infection and its implications within the central nervous system
Matta, S. K., Rinkenberger, N., Dunay, I. R., & Sibley, L. D. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00518-7 · Cited by 261
Intestinal immune responses to commensal and pathogenic protozoa
Sardinha-Silva, A., Alves-Ferreira, E. V. C., & Grigg, M. E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.963723 · Cited by 72
Toxoplasma gondii vaccine candidates: a concise review
Mamaghani, A. J., Fathollahi, A., Arab-Mazar, Z., kohansal, K., Fathollahi, M., Spotin, A., Bashiri, H., & Bozorgomid, A. (2023) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-022-02998-9 · Cited by 51
Metadata
- Authors
- Dupont, C. D., Christian, D. A., & Hunter, C. A.
- Venue
- Seminars in Immunopathology
- Published
- 2012-09-07
- Volume
- 34
- Issue
- 6
- Pages
- 793-813
- ISSN
- 1863-2297 (ISSN-L)
- 1863-2300
- OpenAlex
- W1976689464
- Cited by
- 359
- References
- 233
- FWCI
- 12.29
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.